These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8290672)

  • 21. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. America's mental health: goals and programs of the National Institute of Mental Health.
    Pardes H
    Urban Health; 1981 Nov; 10(9):30-3. PubMed ID: 10313916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Privacy Act of 1974; new system of records--Department of Health and Human Services. Notification of new system of records. Mental Health Epidemiologic and Biometric Research Data.
    Fed Regist; 1981 Jan; 46(7):2722-4. PubMed ID: 10249534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How should efficacy be evaluated in randomized clinical trials of treatments for depression?
    Thase ME
    J Clin Psychiatry; 1999; 60 Suppl 4():23-31; discussion 32. PubMed ID: 10086480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychotropic medications and HIV.
    Thompson A; Silverman B; Dzeng L; Treisman G
    Clin Infect Dis; 2006 May; 42(9):1305-10. PubMed ID: 16586391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mental health in the Medicare Part D drug benefit: a new regulatory model?
    Donohue J
    Health Aff (Millwood); 2006; 25(3):707-19. PubMed ID: 16684735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical decision-making for 'as needed' medications in mental health care.
    Usher K; Baker JA; Holmes C; Stocks B
    J Adv Nurs; 2009 May; 65(5):981-91. PubMed ID: 19291187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contraceptive development--the view from the U.S.A. in the mid 80s].
    Potts M; Siemens A; Burton N
    Contracept Fertil Sex (Paris); 1986 Mar; 14(3):247-51. PubMed ID: 12268061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How well do psychotropic medications match mental health diagnoses? A national view of potential off-label prescribing in VHA nursing homes.
    French DD; Campbell RR; Spehar AM; Accomando J
    Age Ageing; 2007 Jan; 36(1):107-8; author reply 108-9. PubMed ID: 17158114
    [No Abstract]   [Full Text] [Related]  

  • 30. Ethical principles and informed consent: an NIMH perspective.
    Shore D
    Psychopharmacol Bull; 1996; 32(1):7-10. PubMed ID: 8927678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychotherapeutic effects of psychotropic drugs: principle considerations from the psychobiologic viewpoint].
    Langer G
    Wien Med Wochenschr; 1986 Oct; 136(19-20):491-7. PubMed ID: 3027996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001.
    Zuvekas SH
    Health Aff (Millwood); 2005; 24(1):195-205. PubMed ID: 15647230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards a clinical methodology for neuropsychopharmacological research.
    Ban TA
    Neuropsychopharmacol Hung; 2007 Jun; 9(2):81-90. PubMed ID: 17970531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Speed of onset.
    Leber P
    Psychopharmacol Bull; 1995; 31(1):37-40. PubMed ID: 7675987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Neurobiology to Novel Medications: A Principled Approach to Translation.
    Gordon JA
    Am J Psychiatry; 2019 Jun; 176(6):425-427. PubMed ID: 31154816
    [No Abstract]   [Full Text] [Related]  

  • 36. A survey of psychotropic medications not available in the United States.
    Vinar O; Klein DF; Potter WZ; Gause EM
    Neuropsychopharmacology; 1991 Dec; 5(4):201-17. PubMed ID: 1804161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CNS drug development: lessons learned part 2. Symptoms, not syndromes as targets consistent with the NIMH research domain approach.
    Preskorn SH
    J Psychiatr Pract; 2015 Jan; 21(1):60-6. PubMed ID: 25603452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New center to study therapies and ethnicity.
    Holden C
    Science; 1991 Feb; 251(4995):748. PubMed ID: 1990436
    [No Abstract]   [Full Text] [Related]  

  • 39. Neurotechnology: expanding opportunities for funding at the National Institute of Mental Health.
    Huerta MF; Curvey MF; Koslow SH
    J Neurosci Methods; 1994 Oct; 54(2):261-7. PubMed ID: 7869757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Annual NCDEU Meeting (1982)--abridged proceedings. New Clinical Drug Evaluation Unit, National Institute of Mental Health.
    Psychopharmacol Bull; 1983; 19(1):23-140. PubMed ID: 6338549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.